-
<![CDATA[FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women]]>
15 Dec 2025 22:11 GMT
… mg) for the treatment of hypoactive sexual desire disorder (HSDD) in women younger than …
-
<![CDATA[FDA Expands Approval of Flibanserin for Hypoactive Sexual Desire Disorder to Women Younger Than 65 Years]]>
15 Dec 2025 21:44 GMT
… mg for the treatment of hypoactive sexual desire disorder (HSDD) in women younger than …
-
<![CDATA[FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women]]>
15 Dec 2025 20:59 GMT
… flibanserin 100 mg (Addyi) for hypoactive sexual desire disorder (HSDD) in postmenopausal women younger …
-
The FDA Just Approved Addyi, 'The Little Pink Pill,' To Treat Low Sexual Desire In Postmenopausal Women
16 Dec 2025 01:44 GMT
… specifically designed for women experiencing hypoactive sexual desire disorder (HSDD), so it’s not …
-
<![CDATA[FDA approves first postmenopausal libido treatment, Addyi ]]>
16 Dec 2025 01:40 GMT
… ages 65 and younger with hypoactive sexual desire disorder (HSDD), also known as low … of HSDD in premenopausal women.
Hypoactive sexual desire disorder is characterized as a persistent …
-
<![CDATA[FDA Expands Approval of Flibanserin for Postmenopausal Women’s Sexual Health]]>
15 Dec 2025 22:52 GMT
… (Addyi) for the treatment of hypoactive sexual desire disorder (HSDD) in women younger than …
-
<![CDATA[FDA Approval Signals Broader Recognition of Sexual Health in Aging Women]]>
15 Dec 2025 20:10 GMT
… for the treatment of hypoactive sexual desire disorder (HSDD) in women … According to the Mayo Clinic, hypoactive sexual desire disorder (HSDD) is the most … Wawra K, Schmitt S. Hypoactive sexual desire disorder in postmenopausal women. Gynecol Endocrinol …
-
FDA OKs libido-boosting pill for women who have gone through menopause
15 Dec 2025 19:00 GMT
… troublingly low sexual appetite, called hypoactive sexual desire disorder, has been recognized since the …
-
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer
15 Dec 2025 15:00 GMT
… (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder ("HSDD") in premenopausal …
-
Women’s Sexual Healthcare: A Decade of Progress, and the Taboos That Remain.
12 Dec 2025 15:05 GMT
… . It is prescribed specifically for Hypoactive Sexual Desire Disorder (HSDD), defined not by low …